Literature DB >> 2476701

Growth rate of subretinal neovascularization in age-related macular degeneration.

J F Vander1, C M Morgan, H Schatz.   

Abstract

To determine the growth rate of subretinal neovascularization (SRNV) in age-related macular degeneration (ARMD), 35 pairs of serial fluorescein angiograms from 30 consecutive patients with SRNV who had not been treated with laser photocoagulation were analyzed. The daily growth rate of SRNV measured on consecutive fluorescein angiograms less than 120 days apart ranged from 0 to 74 microns (mean, 18 microns daily). The daily estimated growth rate of SRNV in any one direction ranged from 0 to 37 microns (mean, 9 microns daily). Documented initial slow growth of SRNV in one eye did not preclude a greater subsequent growth rate in the fellow eye. It was not possible to predict reliably the growth rate of SRNV. This reinforces the necessity of prompt evaluation of all subretinal neovascular membranes initially for the purpose of possible laser treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2476701     DOI: 10.1016/s0161-6420(89)32740-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes.

Authors:  Yannis M Paulus; Joan L Jefferys; Barbara S Hawkins; Adrienne W Scott
Journal:  Qual Life Res       Date:  2017-03-29       Impact factor: 4.147

2.  The significance of early treatment of exudative age-related macular degeneration: 12 months' results.

Authors:  Birgit Weingessel; Gregor Hintermayer; Saskia M Maca; Renate Rauch; Pia Veronika Vecsei-Marlovits
Journal:  Wien Klin Wochenschr       Date:  2012-10-24       Impact factor: 1.704

3.  Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis.

Authors:  Handan Canan; Selçuk Sızmaz; Rana Altan-Yaycıoğlu; Cağla Sarıtürk; Gürsel Yılmaz
Journal:  Clin Interv Aging       Date:  2014-01-10       Impact factor: 4.458

4.  Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial.

Authors:  Ava K Bittner; Sheryl Torr-Brown; Ellen Arnold; Antonia Nwankwo; Patricia Beaton; Radhika Rampat; Gislin Dagnelie; Mark Roser
Journal:  J Clin Exp Ophthalmol       Date:  2014-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.